Authors | Age | Reproductive history | β-hCG (mIU/ml) | Surgery | Chemotherapy | Outcome | DNA polymorphic analysis |
---|---|---|---|---|---|---|---|
Gestational choriocacinoma | |||||||
 Lorigan,1996 [24] | 41 | NS | 151,500 | TAH,BSO | BEP then EI | NED | Yes |
 Our case | 27 | G0 | >200,000 | ROC | EP-EMA | NED 32 mo | Yes |
Non-gestational choriocacinoma | |||||||
 Vance,1985 [5] | 9 | NI | 34 | RO | VEP | NED 12 mo | No |
 Raju,1985 [6] | 16 | NI | NS | Autopsy | None | DOD | No |
 Axe,1985 [1] | 6 | NI | Normal | RO | None | NED 10 yrs | No |
 Axe,1985 [1] | 11 | NI | Elevated | RO | MAV | DOD | No |
 Sengupta, 1987 [7] | 11 | NI | NS | UO | NS | NS | No |
 Spingler,1990 [19] | 20 | Swyer syndrome | NS | Yes,NS | NS | DOD | No |
 Gribbon,1992 [8] | NS | NI | Elevated | Yes,NS | NS | DOD 4 mo | No |
 Gribbon,1992 [8] | 11 | NI | Elevated | Yes,NS | NS | NED 1 yr | No |
 Brown,1993 [9] | 11 | NI | NS | USO | NS | NED 32 mo | No |
 Trigueros,1995 [10] | 21 | NI | 200,000 | TAH,BSO | PVB | NED 4 yrs | No |
 Gungor,1999 [11] | 16 | NI | 20,000 | TAH, cytodeduction, omentectomy, appendectomy | EMA-CO | DOD 6 mo | No |
 Inaba,2000 [12] | 12 | NI | 1,100,000 | RSO,LOC, conservative debulking surgery | BEP then EIC | NED 12 mo | No |
 Goswami, 2001 [13] | 18 | NI | 88,385 | LSO,ROC,omental and peritoneal biopsies | MA and oral chlorambucil | NED 5 mo | No |
 Ozdemir, 2002 [14] | 13 | NI | 91,028 | RSO | MAC | NED 9 mo | No |
 Tsujioka, 2003 [20] | 19 | NS | 110,000 | LSO | EMA-CO | NS | Yes |
 Koo,2006 [21] | 33 | G0 | 185,000 | TAH,BSO,PLND | MAC | NED 18 mo | Yes |
 Yamamoto,2007 [22] | 19 | NS | 206,949 | LO | EMA,then EA | NED 12 mo | Yes |
 Kong,2009 [4] | 10 | NI | NS | LSO,partial omentectomy | PVB | NED 3 mo | No |
 Exman,2013 [23] | 24 | G1P0 | 675,713 | TAH,BSO | BEP | NED | Yes |
 Heo,2014 [15] | 12 | NI | 20,257 | LSO | BEP | NED 14 mo | No |
 Hayashi,2015 [16] | 10 | NI | 6600 | RSO | BEP | NED 62 mo | No |
 Xin,2015 [17] | 23 | NI | 18,000 | tumor enucleation, LSO, pelvic peritonectomy, PaLND, omentectomy | BEP | NED 9 mo | No |
 Wang,2016 [18] | 13 | NI | Elevated | TAH,LSO,debulking surgery | PVB | DOD 3 mo | No |
 Wang,2016 [18] | 13 | NI | NS | LSO | NS | Lost follow-up in 1 yr | No |
Uncertain etiology | |||||||
 Jacobs,1982 [33] | 30 | G1P1 | 350,000 | lumpectomy | MTX | NED 2 yrs | No |
 Axe,1985 [1] | 21 | G1P1 | Elevated | RO | MAV | NED 8 yrs | No |
 Axe,1985 [1] | 20 | NS | Elevated | RO,appendectomy | MTX | NED 16 yrs | No |
 Axe,1985 [1] | 36 | G4P2 | Elevated | TAH,BSO,appendectomy | MTX | NED 19 yrs | No |
 Axe,1985 [1] | 35 | G4P4 | Elevated | TAH,BSO,PLND | PBC | NED 9 mo | No |
 Kim,1990 [35] | 16 | G0 | 565,000 | TAH,BSO | MAC | DOD during chemo | unknown |
 Shin,1994 [36] | 45 | G6P3 | 132,005 | TAH,BSO | MAC | NED 1 yr | unknown |
 Byeun,1995 [37] | 28 | G3P2 | 13,378 | RSO | EMA | NED 1 yr | unknown |
 Balat,2004 [38] | 28 | NS | 13,378 | TAH,BSO,PLND | BEP | DOD during chemo | No |
 Bazot,2004 [39] | 38 | P0 | 2,460,000 | TAH,BSO | NS | NED 7 yrs | No |
 Gerson,2005 [25] | 33 | G5P3 | 564,000 | RSO,TAH,LSO,splenectomy | EMA-CO | NED 12 mo | No |
 Corakci,2005 [34] | 22 | G1P1 | 15,050 | TAH,BSO,PLND,PaLND | BEP | NED 25 mo | No |
 Hirabayashi,2006 [40] | 50 | G0 | 704 | TAH,RSO,PLND | P(ip) + TC,EP-EMA,P-EMA(ip) | DOD 10 mo | No |
 Roghaei,2007[41] | 47 | G5P5, menopause | 970 | TAH,BSO,PLND | EMA-CO | NED | No |
 Park,2009 [26] | 55 | G5P3 | 64,838 | TAH,BSO | BEP | NED 20 mo | No |
 Mood,2009 [42] | 31 | G9P1 | >1000 | RSO | EMA-CE | NED 7 yrs | No |
 Mood,2009 [42] | 32 | G3P2 | 5500 | TAH, BSO, debulking surgery and omentectomy | BEP to EMA-CE | NED 5 yrs | No |
 Gon,2010 [43] | 21 | G0 | 279,000 | RSO | NS | NS | No |
 Lv,2011 [2] | 48 | G1P1 | 7664 | sub-extensive TAH,BSO,PLND,PaLND | BEP | NED 12 mo | No |
 Choi,2013 [27] | 33 | G4P2 | 74,612 | LO,ROC | EMA | NED 5 yrs | No |
 Haruma,2015 [44] | 19 | G0 | 373,170 | LSO | EMA-CO | NED 10 mo | No |
 Rao,2015 [45] | 26 | G1P1 | 8160 | RSO,partial omentectomy, partial splenectomy and right adrenalectomy | BEO | brain metastasis 2 years after primary treatment | No |